You are here: Industry Insights > ChAdOx1 nCoV-19

News List

CDSCO grants permission to three private COVID-19 vaccines for restricted use in emergency situation expresspharma
July 21, 2021
The information was given today by Mansukh Mandaviya, Union Minister of Chemicals and Fertilizers, in a written reply in the Lok Sabha.
Oxford University launches Covid-19 vaccine study in children pharmaceutical-technology
February 18, 2021
The University of Oxford has launched the first study of ChAdOx1 nCoV-19 Covid-19 vaccine in children and young adults.
Oxford Covid-19 vaccine doses improve immune response in animals pharmaceutical-technology
June 28, 2020
A study conducted by the Pirbright Institute, in alliance with the University of Oxford, has demonstrated that two doses of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine boost antibody response in pigs, compared to a single dose.
Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax contractpharma
May 29, 2020
The first 4,000 doses have been delivered for use in the Phase II/III clinical trial COV002 by the University of Oxford.
Project leader: Oxford’s COVID-19 vaccine trial has 50 per cent chance of success expresspharma
May 27, 2020
The experimental vaccine, known as ChAdOx1 nCoV-19, is one of the front-runners in the global race to provide protection against the new coronavirus causing the COVID-19 pandemic.
AstraZeneca and Oxford University partner on Covid-19 vaccine pharmaceutical-technology
April 30, 2020
AstraZeneca has signed an agreement with the University of Oxford to develop and distribute the university’s Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
Serum Institute plans to price coronavirus vaccine at ?1,000 if trials succeed expresspharma
April 29, 2020
The Serum Institute of India announced that it plans this year to produce up to 60 million doses of a potential vaccine against the new coronavirus that is under clinical trial in Britain.
UK COVID-19 vaccine candidate to be manufactured at seven outsourced sites europeanpharmaceuticalreview
April 24, 2020
Following the initiation of a clinical trial, a COVID-19 vaccine candidate developed by UK researchers is being manufactured in several outsourced facilities.
UK COVID-19 vaccine to begin human testing pharmatimes
April 22, 2020
As of this morning – Wednesday April 22 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 129,044 with 17,337 deaths.